TAP Pharmaceuticals
TAP Pharmaceuticals was a joint venture between the pharmaceutical companies Abbott Laboratories and Takeda Pharmaceutical Company. Established in 1977, TAP Pharmaceuticals was known for the development and marketing of the drugs Lupron, Prevacid and Prevpac. The company was dissolved in 2008, with both parent companies taking over the products.
History[edit | edit source]
TAP Pharmaceuticals was formed in 1977 as a 50/50 joint venture between Abbott Laboratories, a U.S. based health care company, and Takeda Pharmaceutical Company, a Japan-based pharmaceutical company. The aim of the joint venture was to develop and market pharmaceutical products in the United States.
TAP Pharmaceuticals gained significant recognition for the development and marketing of Lupron, a drug used in the treatment of prostate cancer, endometriosis, and early puberty. Other notable drugs developed by TAP Pharmaceuticals include Prevacid, used for the treatment of gastroesophageal reflux disease (GERD), and Prevpac, a combination of lansoprazole, amoxicillin, and clarithromycin used for the treatment of Helicobacter pylori infection and duodenal ulcer disease.
In 2001, TAP Pharmaceuticals agreed to pay $875 million to settle federal criminal and civil charges for fraudulent drug pricing and marketing of Lupron. This was one of the largest amounts ever paid by a pharmaceutical company in a settlement at that time.
In 2008, Abbott Laboratories and Takeda Pharmaceutical Company decided to dissolve TAP Pharmaceuticals. The decision was made due to changes in the pharmaceutical industry and the upcoming patent expiration of Prevacid. Following the dissolution, both parent companies took over the marketing and development of the products.
Products[edit | edit source]
TAP Pharmaceuticals was known for the development and marketing of several significant drugs. These include:
- Lupron: A hormone therapy used in the treatment of prostate cancer, endometriosis, and early puberty.
- Prevacid: A proton pump inhibitor used for the treatment of gastroesophageal reflux disease (GERD).
- Prevpac: A combination of lansoprazole, amoxicillin, and clarithromycin used for the treatment of Helicobacter pylori infection and duodenal ulcer disease.
See Also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
